EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lacticaseibacillus rhamnosus Probio-M9 Alters the Gut Microbiota and Mitigates Pulmonary Hypertension in a Rat Model

Zhixin Zhao, Gaopeng Li, Kiyomi Ohmichi, Xiaodong Li iD, Feiyan Zhao, Kaori Ishikawa iD, Ryou Ishikawa iD, Kazufumi Nakamura iD, Naoya Yokota, Zhihong Sun, Lin Hai Kurahara iD

Nutrients · 2025

DOI: 10.3390/nu17182927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Zhixin Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Hypertension, Pulmonary, Lacticaseibacillus rhamnosus, Probiotics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KAKENHI, Kagawa University and KAKENHI, MEXT-Supported Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal microbiota plays an important role in the progression of pulmonary hypertension (PH). Colostrum-derived Lacticaseibacillus rhamnosus Probio-M9 (Probio-M9) has shown protective effects against inflammation and remodeling. We investigated whether Probio-M9 supplementation could improve the pathology of PH.

Methods

The monocrotaline (MCT)-induced PH model rats are created followed by Probio-M9 treatment. Microbiota and pathological analyses were performed to investigate the therapeutic effects of Probio-M9.

Results

Probio-M9 significantly suppressed cardiovascular remodeling and reduced mortality in rats. Analysis of the fecal microbiota revealed that Probio-M9 significantly altered the gut microbiota of MCT model rats. Specifically, Alistipes sp009774895 and Duncaniella muris populations increased, whereas Limosilactobacillus reuteri_D, Ligilactobacillus apodeme and Monoglobus sp900542675 decreased compared to those in the MCT group. Focusing on the expression of GPNMB in macrophages and the localization of CD44, we found that the number of these cells increased in the MCT group but significantly decreased with Probio-M9 treatment. In lung tissue from PH patients, more GPNMB-positive macrophages were found than non-PH lungs, and an increase in CD44-positive cells was confirmed in the vicinity of GPNMB.

Conclusions

Probio-M9 had a significant impact on the intestinal microbiota and GPNMB/CD44 positive cells in the lungs of PH rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeHypertension, PulmonaryLacticaseibacillus rhamnosusProbioticsAnimalsRatsDisease Models, AnimalMaleRats, Sprague-DawleyLungMonocrotalineHumans

Stichwörter der Autor:innen

CD44GPNMBgut microbiotamacrophagesprobioticspulmonary artery remodeling

Substanzen

Monocrotaline

Autor:innen und Institutionen

  • Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs, Key Laboratory of Dairy Biotechnology and Engineering, Minist…
  • Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Kagawa, Japan.
  • Department of Diagnostic Pathology, Kagawa University Hospital, Takamatsu 761-0793, Kagawa, Japan.
  • Department of General Medicine, Kagawa University Hospital, Takamatsu 761-0793, Kagawa, Japan.
  • Center for Advanced Heart Failure, Okayama University Hospital, Okayama 700-8558, Okayama, Japan.
  • Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, Kita-gun, Miki-cho 761-0793, Kagawa, Japan.

ORCID-Profile: Xiaodong Li, Kaori Ishikawa, Ryou Ishikawa, Kazufumi Nakamura, Lin Hai Kurahara

Förderung

  • KAKENHI
  • Kagawa University and KAKENHI
  • MEXT-Supported Program
  • Gender Equality Promotion Office of Kagawa University

Zitieren

APA

Zhao, Z., Li, G., Ohmichi, K., Li, X., Zhao, F., Ishikawa, K., Ishikawa, R., Nakamura, K., Yokota, N., Sun, Z., & Kurahara, L. H. (2025). Lacticaseibacillus rhamnosus Probio-M9 Alters the Gut Microbiota and Mitigates Pulmonary Hypertension in a Rat Model. Nutrients. https://doi.org/10.3390/nu17182927

Vancouver

Zhao Z, Li G, Ohmichi K, Li X, Zhao F, Ishikawa K, et al. Lacticaseibacillus rhamnosus Probio-M9 Alters the Gut Microbiota and Mitigates Pulmonary Hypertension in a Rat Model. Nutrients. 2025. doi:10.3390/nu17182927

BibTeX
@article{Zhao2025,
  author = {Zhao, Zhixin and Li, Gaopeng and Ohmichi, Kiyomi and Li, Xiaodong and Zhao, Feiyan and Ishikawa, Kaori and Ishikawa, Ryou and Nakamura, Kazufumi and Yokota, Naoya and Sun, Zhihong and Kurahara, Lin Hai},
  title = {Lacticaseibacillus rhamnosus Probio-M9 Alters the Gut Microbiota and Mitigates Pulmonary Hypertension in a Rat Model},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17182927}
}
Kostenlos starten →